FGF2 and diabetes mellitus: In this context, we hypothesised that bFGF could modulate the gene expression profile of subcutaneous and visceral ASCs from individuals with obesity and type 2 diabetes to restore the stem cell function impaired by diabetes and promote microvascular vessel formation, stabilisation and maturation, thereby ameliorating vascular dysfunction associated with excess fat accumulation.